Department of Nuclear Medicine

Medicine & Life Sciences

1. Fluorodeoxyglucose F18 100%
2. Breast Neoplasms 57%
3. Positron Emission Tomography Computed Tomography 44%
4. Positron-Emission Tomography 34%
5. Breast 29%
6. Lymph Nodes 25%
7. Neoplasms 21%
8. Cone-Beam Computed Tomography 21%
9. Dental Pulp Cavity 20%
10. Recurrence 16%
11. Glycolysis 12%
12. 4-phenyl-1,2,3,6-tetrahydropyridine 12%
13. Neoplasm Metastasis 12%
14. Single Photon Emission Computed Tomography Computed Tomography 11%
15. Magnetic Resonance Imaging 11%
16. Tumor Burden 10%
17. Glucose 10%
18. Rectal Neoplasms 10%
19. Carcinoma, Intraductal, Noninfiltrating 10%
20. Chemoradiotherapy 9%
21. Ductal Carcinoma 9%
22. Transcranial Magnetic Stimulation 9%
23. 68Ga-1,4,7-triazacyclononane-1,4-7-triacetic acid-isothiocyanatobenzyl-c(Arg-Gly-Asp-Tyr-Lys) 9%
24. Lymphoscintigraphy 9%
25. Single-Photon Emission-Computed Tomography 8%
26. Hospital Emergency Service 8%
27. Temporal Lobe 8%
28. Estrogen Receptors 8%
29. Deoxyglucose 7%
30. benzylguanidine 7%
31. Confidence Intervals 7%
32. camphene 7%
33. Carcinoma, Ductal, Breast 7%
34. Uterine Cervical Neoplasms 7%
35. 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 7%
36. Brain 7%
37. Adenoma 7%
38. Radionuclide Imaging 7%
39. Osteonecrosis 7%
40. Stomach Neoplasms 7%
41. Muscular Atrophy 7%
42. 1,4,7-triazacyclononane-N,N',N''-triacetic acid 7%
43. technetium 99m methoxyisobutylisonitrile 6%
44. Tomography 6%
45. Multivariate Analysis 6%
46. CT protocol 6%
47. Dentin-Bonding Agents 6%
48. Technetium Tc 99m Dimercaptosuccinic Acid 6%
49. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 6%
50. PET protocol 5%
51. Sensitivity and Specificity 5%
52. Periapical Periodontitis 5%
53. Breast Carcinoma In Situ 5%
54. Tooth 5%
55. Amyloid 5%
56. Extracorporeal Shockwave Therapy 5%
57. mineral trioxide aggregate 5%
58. Population 5%
59. Survival 5%
60. Non-Small Cell Lung Carcinoma 5%
61. HIV 5%
62. Retrospective Studies 5%
63. Regression Analysis 5%
64. human ERBB2 protein 5%
65. HSP90 Heat-Shock Proteins 5%
66. Vancomycin-Resistant Enterococci 5%
67. Condylomata Acuminata 5%
68. Zoledronic Acid 5%
69. Skeletal Muscle 5%
70. Sodium Fluoride 5%
71. Large-Core Needle Biopsy 5%
72. Becaplermin 5%
73. Odds Ratio 5%
74. Parathyroid Neoplasms 5%
75. Iodides 5%
76. Progesterone Receptors 5%
77. Inbred DBA Mouse 5%
78. Mammography 5%
79. Decontamination 5%
80. Circulating Neoplastic Cells 5%
81. Macaca fascicularis 5%